Vertex Pharmaceuticals Incorporated shares owned by Douglass Winthrop Advisors
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Douglass Winthrop Advisors
from 13F filings
Historical chart of Douglass Winthrop Advisors investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Douglass Winthrop Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Douglass Winthrop Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $381k | 937 | 406.89 |
| 2023-09-30 | $326k | 937 | 347.74 |
| 2023-06-30 | $323k | 918 | 351.91 |
| 2023-03-31 | $289k | 918 | 314.81 |
| 2022-12-31 | $265k | 918 | 288.67 |
| 2022-09-30 | $266k | 918 | 289.76 |
| 2022-06-30 | $259k | 918 | 282.14 |
| 2022-03-31 | $240k | 918 | 261.44 |
| 2021-12-31 | $202k | 918 | 220.04 |
| 2020-12-31 | $225k | 954 | 235.85 |
| 2020-09-30 | $318k | 1.2k | 272.03 |
| 2020-06-30 | $397k | 1.4k | 289.99 |
| 2020-03-31 | $343k | 1.4k | 237.70 |
| 2019-12-31 | $338k | 1.5k | 218.91 |
| 2019-09-30 | $262k | 1.5k | 169.69 |
| 2019-06-30 | $283k | 1.5k | 183.29 |
| 2019-03-31 | $284k | 1.5k | 183.94 |
| 2018-12-31 | $256k | 1.5k | 165.80 |
| 2018-09-30 | $318k | 1.7k | 192.73 |
| 2018-06-30 | $314k | 1.9k | 169.73 |
| 2018-03-31 | $345k | 2.1k | 163.12 |
| 2017-12-31 | $318k | 2.1k | 149.72 |
| 2017-09-30 | $323k | 2.1k | 152.07 |
| 2017-06-30 | $271k | 2.1k | 129.05 |
| 2016-09-30 | $262k | 3.0k | 87.33 |
| 2016-06-30 | $260k | 2.5k | 104.00 |
| 2015-12-31 | $295k | 2.5k | 118.00 |
| 2015-09-30 | $295k | 2.5k | 118.00 |
| 2015-06-30 | $295k | 2.5k | 118.00 |
| 2015-03-31 | $295k | 2.5k | 118.00 |
More positions owned by Douglass Winthrop Advisors
View all positions for Douglass Winthrop Advisors
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated